Treatment of Melanoma

Por Garbe, Claus, Terheyden, Patrick, Keilholz, Ulrich, Kölbl, Oliver, Hauschild, Axel
Publicado em 2008

Basal Cell Carcinoma—Treatments for the Commonest Skin Cancer

Por Berking, Carola, Hauschild, Axel, Kölbl, Oliver, Mast, Gerson, Gutzmer, Ralf
Publicado em 2014

The Impact of Multispectral Digital Skin Lesion Analysis on German Dermatologist Decisions to Biopsy Atypical Pigmented Lesions with Clinical Characteristics of Melanoma

Por Winkelmann, Richard R., Hauschild, Axel, Tucker, Natalie, White, Richard, Rigel, Darrell S.
Publicado no J Clin Aesthet Dermatol (2015)

Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects

Por Garbe, Claus, Eigentler, Thomas K., Keilholz, Ulrich, Hauschild, Axel, Kirkwood, John M.
Publicado em 2011

Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials

Por Dummer, Reinhard, Schadendorf, Dirk, Ascierto, Paolo A, Larkin, James, Lebbé, Celeste, Hauschild, Axel
Publicado em 2014

Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations

Por Cierlitza, Monika, Chauvistré, Heike, Bogeski, Ivan, Zhang, Xin, Hauschild, Axel, Herlyn, Meenhard, Schadendorf, Dirk, Vogt, Thomas, Roesch, Alexander
Publicado no Exp Dermatol (2015)

Telomerase Activity in Melanocytic Lesions : A Potential Marker of Tumor Biology

Por Rudolph, Pierre, Schubert, Christoph, Tamm, Sontka, Heidorn, Klaus, Hauschild, Axel, Michalska, Iwona, Majewski, Slavomir, Krupp, Guido, Jablonska, Stephania, Parwaresch, Reza
Publicado em 2000

The Neuropeptide Alpha-Melanocyte-Stimulating Hormone Is Critically Involved in the Development of Cytotoxic CD8(+) T Cells in Mice and Humans

Por Loser, Karin, Brzoska, Thomas, Oji, Vinzenz, Auriemma, Matteo, Voskort, Maik, Kupas, Verena, Klenner, Lars, Mensing, Cornelius, Hauschild, Axel, Beissert, Stefan, Luger, Thomas A.
Publicado em 2010

Progression of cutaneous melanoma: implications for treatment

Por Leong, Stanley P. L., Mihm, Martin C., Murphy, George F., Hoon, Dave S. B., Kashani-Sabet, Mohammed, Agarwala, Sanjiv S., Zager, Jonathan S., Hauschild, Axel, Sondak, Vernon K., Guild, Valerie, Kirkwood, John M.
Publicado no Clin Exp Metastasis (2012)

Erratum to: Progression of cutaneous melanoma: implications for treatment

Por Leong, Stanley P. L., Mihm, Martin C., Murphy, George F., Hoon, Dave S. B., Kashani-Sabet, Mohammed, Agarwala, Sanjiv S., Zager, Jonathan S., Hauschild, Axel, Sondak, Vernon K., Guild, Valerie, Kirkwood, John M.
Publicado no Clin Exp Metastasis (2012)

A Multi-Marker Prognostic Assay for Primary Cutaneous Melanoma

Por Kashani-Sabet, Mohammed, Venna, Suraj, Nosrati, Mehdi, Rangel, Javier, Sucker, Antje, Egberts, Friederike, Baehner, Frederick L., Simko, Jeff, Leong, Stanley P.L., Haqq, Chris, Hauschild, Axel, Schadendorf, Dirk, Miller, James R., Sagebiel, Richard W.
Publicado em 2009

Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma

Por Lacouture, Mario E., Dréno, Brigitte, Ascierto, Paolo Antonio, Dummer, Reinhard, Basset-Seguin, Nicole, Fife, Kate, Ernst, Scott, Licitra, Lisa, Neves, Rogerio I., Peris, Ketty, Puig, Susana, Sokolof, Jonas, Sekulic, Aleksandar, Hauschild, Axel, Kunstfeld, Rainer
Publicado no Oncologist (2016)

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma

Por Zimmer, Lisa, Vaubel, Julia, Mohr, Peter, Hauschild, Axel, Utikal, Jochen, Simon, Jan, Garbe, Claus, Herbst, Rudolf, Enk, Alexander, Kämpgen, Eckhart, Livingstone, Elisabeth, Bluhm, Leonie, Rompel, Rainer, Griewank, Klaus G., Fluck, Michael, Schilling, Bastian, Schadendorf, Dirk
Publicado no PLoS One (2015)

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

Por Zimmer, Lisa, Eigentler, Thomas K., Kiecker, Felix, Simon, Jan, Utikal, Jochen, Mohr, Peter, Berking, Carola, Kämpgen, Eckhart, Dippel, Edgar, Stadler, Rudolf, Hauschild, Axel, Fluck, Michael, Terheyden, Patrick, Rompel, Rainer, Loquai, Carmen, Assi, Zeinab, Garbe, Claus, Schadendorf, Dirk
Publicado no J Transl Med (2015)

Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition

Por Zimmer, Lisa, Hillen, Uwe, Livingstone, Elisabeth, Lacouture, Mario E., Busam, Klaus, Carvajal, Richard D., Egberts, Friederike, Hauschild, Axel, Kashani-Sabet, Mohammed, Goldinger, Simone M., Dummer, Reinhard, Long, Georgina V., McArthur, Grant, Scherag, André, Sucker, Antje, Schadendorf, Dirk
Publicado em 2012

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

Por Mangana, Joanna, Cheng, Phil F., Schindler, Katja, Weide, Benjamin, Held, Ulrike, Frauchiger, Anna L., Romano, Emanuella, Kähler, Katharina C., Rozati, Sima, Rechsteiner, Markus, Moch, Holger, Michielin, Olivier, Garbe, Claus, Hauschild, Axel, Hoeller, Christoph, Dummer, Reinhard, Goldinger, Simone M.
Publicado no PLoS One (2015)

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG “GERMELATOX survey”) versus melanoma recurrence to quantify patients’ relative values for ad...

Por Kaehler, Katharina C., Blome, Christine, Forschner, Andrea, Gutzmer, Ralf, Haalck, Thomas, Heinzerling, Lucie, Kornek, Thomas, Livingstone, Elisabeth, Loquai, Carmen, Maul, Lara Valeska, Lang, Berenice M., Schadendorf, Dirk, Stade, Barbara, Terheyden, Patrick, Utikal, Jochen, Wagner, Tobias, Hauschild, Axel, Garbe, Claus, Augustin, Matthias
Publicado no Medicine (Baltimore) (2016)

Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials

Por Flaherty, Keith T, Hennig, Michael, Lee, Sandra J, Ascierto, Paolo A, Dummer, Reinhard, Eggermont, Alexander M M, Hauschild, Axel, Kefford, Richard, Kirkwood, John M, Long, Georgina V, Lorigan, Paul, Mackensen, Andreas, McArthur, Grant, O'Day, Steven, Patel, Poulam M, Robert, Caroline, Schadendorf, Dirk
Publicado no Lancet Oncol (2014)

Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma

Por Lacouture, Mario E., Duvic, Madeleine, Hauschild, Axel, Prieto, Victor G., Robert, Caroline, Schadendorf, Dirk, Kim, Caroline C., McCormack, Christopher J., Myskowski, Patricia L., Spleiss, Olivia, Trunzer, Kerstin, Su, Fei, Nelson, Betty, Nolop, Keith B., Grippo, Joseph F., Lee, Richard J., Klimek, Matthew J., Troy, James L., Joe, Andrew K.
Publicado em 2013

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

Por Sekulic, Aleksandar, Migden, Michael R., Oro, Anthony E., Dirix, Luc, Lewis, Karl D., Hainsworth, John D., Solomon, James A., Yoo, Simon, Arron, Sarah T., Friedlander, Philip A., Marmur, Ellen, Rudin, Charles M., Chang, Anne Lynn S., Low, Jennifer A., Mackey, Howard M., Yauch, Robert L., Graham, Richard A., Reddy, Josina C., Hauschild, Axel
Publicado no N Engl J Med (2012)